Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
NantKwest Signs Worldwide License Agreement with ProMab Biotechnologies
Tuesday, March 05, 2019NantKwest Inc a leading clinicalstage Natural Killer NK cell based therapeutics company and ProMab Biotechnologies today announced the establishment of a worldwide license to a BCell Maturation Antigen BCMA targeted antibody sequence for multiple mye...
Medexus Enters into Expanded Licensing Agreement for Gliolan® in Canada
Tuesday, March 05, 2019Medexus Pharmaceuticals Inc today announced that it has entered into a licensing agreement with photonamic GmbH Co KG photonamic for the exclusive rights to market and distribute Gliolan in Canada which assists neurosurgeons to better visualize and...
3SBio and TLC Form Exclusive Partnership to Commercialize Two NanoX™ Products in Mainland China
Monday, March 04, 2019SBio Incand Taiwan Liposome Company Ltd today announced an exclusive partnership to commercialize in mainland China two liposomal products utilizing TLCs proprietary NanoX technology platform in the therapeutic areas of oncology and severe infectious...
AdoRx Therapeutics Announces Collaboration With Johnson & Johnson Innovation to Develop Novel Lung Cancer Therapeutics
Saturday, March 02, 2019AdoRx Therapeutics a UK based drug discovery company today announced that it has entered into a strategic collaboration with Johnson Johnson Innovation LLC and the Lung Cancer Initiative at Johnson Johnson to develop novel therapeutics for the trea...
AbCellera and Denali Therapeutics Sign Expanded Multi-Year, Multi-Target Deal to Discover Therapeutic Antibodies
Friday, March 01, 2019AbCellera today announced an expanded collaboration with Denali Therapeutics Inc NASDAQDNLI to discover antibodies as therapies for neurological indications AbCellera will generate panels of antibodies for up to eight drug targets nominated by Denali...
Abpro and NJCTTQ Enter Into Partnership for Development of Multiple Novel Bispecific Antibodies
Friday, March 01, 2019Abpro a biotechnology company dedicated to developing nextgeneration antibody therapeutics to improve the lives of patients with severe and lifethreatening diseases and NJCTTQ a global pharmaceutical company today announced that they have entered int...
Genesis Drug Discovery & Development Announces Operating Agreement with Ophthy-DS, Inc.
Thursday, February 28, 2019PharmOptima a member of Genesis Drug Discovery Development GD the contract research organization CRO arm of Genesis Biotechnology Group GBG and OphthyDS a preclinical CRO providing ocular drug discovery services have announced a collaborative operat...
Sarepta Exercises Option to Acquire Myonexus Therapeutics
Thursday, February 28, 2019Sarepta Therapeutics Inc the leader in precision genetic medicine for rare diseases announced today that it has exercised its option to acquire Myonexus Therapeutics a clinicalstage biotechnology company developing transformative gene therapies for f...
Imbrium Therapeutics and TetraGenetics Announce Strategic Research Collaboration and License Option to Develop Novel Biologic Therapeutics
Wednesday, February 27, 2019Imbrium Therapeutics LP a clinicalstage biopharmaceutical company and operating subsidiary of Purdue Pharma LP and TetraGenetics Inc a biotech company developing novel therapeutics for pain indications and autoimmune diseases today announced a strate...
Selexis SA and Turgut Pharmaceuticals Expand Biosimilar Development Relationship by Signing Two Commercial License Agreements
Wednesday, February 27, 2019Selexis SA and Turgut Pharmaceuticals Turgut Ilaclari AS announced today that they have signed two commercial license agreements CLAs through which Turgut will leverage Selexis SUREtechnology Platform and SURE CHOM Cell Line for the development of tw...
